Gottlieb: WH Had Pfizer Data, Still Declined To Buy More Vaccine Doses

The transcript discusses the complexities of vaccine negotiations and contracts, highlighting Pfizer's offer of additional vaccine doses and the White House's rejection of it. It also covers the executive order signed by President Trump prioritizing American vaccination and the challenges faced by Operation Warp Speed. The discussion includes the future availability of vaccines and existing contracts with Pfizer, emphasizing the uncertainty and strategic decisions involved in vaccine distribution.

What was the main reason the White House rejected Pfizer's offer for more vaccine doses?

• The vaccine was not yet proven effective.

• The vaccine had too many side effects.

• The vaccine was too expensive.

• The vaccine was not available in sufficient quantities.

Who confirmed that Pfizer made multiple offers for additional vaccine doses?

• Alex Azar

• Dr. Scott Gottlieb

• President Donald Trump

• The New York Times

Why was it challenging to decide on purchasing more doses from a single vaccine manufacturer?

• The vaccines required special storage conditions.

• The vaccines were too expensive.

• The vaccines were not approved by the FDA.

• There was uncertainty about which vaccine would be most effective.

What did President Trump's executive order prioritize?

• Exporting vaccines to other countries

• Increasing vaccine production

• Reducing vaccine costs

• Vaccinating Americans before others

By when does the US expect to have vaccines available for the general population?

• By the end of the year

• By April

• By next summer

• By next fall